Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02726113 · ClinicalTrials.gov registry record · Phase 2
Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT02726113 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 50 participants.
The verdict
NCT02726113, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study population will be 80 adult men who have been diagnosed with prostate cancer who are scheduled to have their prostate surgically removed at either the Medical University of South Carolina (MUSC) or the Ralph H. Johnson VAMC, both located in Charleston, SC. The men will be randomized into two groups: one group will take vitamin D3 supplementation and the other will take a placebo. Blood levels of vitamin D3 will be obtained at the beginning of the study and again after two months, just prior to the surgical procedure (prostatectomy). Prostate tissue will be obtained from the surgical procedure and studied for the effect of vitamin D on the prostate cancer cells.
Interventions
- OTHER placebo
- DRUG cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02726113
The ClinicalTrials.gov registry entry for NCT02726113 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02726113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02726113 about?
NCT02726113 is a clinical study titled "Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy". The study population will be 80 adult men who have been diagnosed with prostate cancer who are scheduled to have their prostate surgically removed at either the Medical University of South Carolina (MUSC) or the Ralph H. Johnson VAMC, both located in Charleston, SC. The men will be randomized into t...
What is the current status of trial NCT02726113?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2011-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02726113?
The interventions under investigation include: placebo (OTHER), cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT02726113?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.